Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3707 USD | -0.88% | +1.84% | -13.81% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.36M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-0.49
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.16% |
Latest transcript on Theriva Biologics, Inc.
1 day | -0.88% | ||
1 week | +1.84% | ||
Current month | -7.90% | ||
1 month | -17.25% | ||
3 months | -21.13% | ||
6 months | -9.61% | ||
Current year | -13.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.3707 | -0.88% | 36,012 |
24-05-16 | 0.374 | +0.81% | 84,810 |
24-05-15 | 0.371 | -0.80% | 48,901 |
24-05-14 | 0.374 | -0.03% | 113,405 |
24-05-13 | 0.3741 | +2.77% | 72,422 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.81% | 6.36M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- TOVX Stock